Quick Answer
Insight Molecular Diagnostics Inc. reported R&D Expense of $15.90 million for fiscal year 2025.
Insight Molecular Diagnostics Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $15.90M | +61.6% |
| 2024 | $9.84M | +5.9% |
| 2023 | $9.29M | +27.3% |
| 2022 | $7.30M | +45.0% |
| 2021 | $5.04M | -48.6% |
| 2020 | $9.80M | +44.2% |
| 2019 | $6.79M | +4.3% |
| 2018 | $6.51M | -9.2% |
| 2017 | $7.17M | +26.4% |
| 2016 | $5.68M | +25.4% |
| 2015 | $4.53M | +14.3% |
| 2014 | $3.96M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.88M | +37.7% | +18.2% |
| June 30, 2025 | $3.28M | +33.8% | +12.2% |
| March 31, 2025 | $2.92M | +26.5% | +3.8% |
| September 30, 2024 | $2.82M | +28.9% | +14.8% |
| June 30, 2024 | $2.45M | +0.7% | +6.1% |
| March 31, 2024 | $2.31M | +8.7% | +5.8% |
| September 30, 2023 | $2.19M | +48.4% | -10.3% |
| June 30, 2023 | $2.44M | -0.4% | +14.5% |
- Insight Molecular Diagnostics Inc. showed an increase of +61.6% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, Insight Molecular Diagnostics Inc.’s r&d expense has grown by 301.3% (from $3.96 million to $15.90 million).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: